Loading organizations...
§ Private Profile · San Diego, CA, USA
AI-powered finance and accounting software for biopharmaceutical companies, automating clinical accruals and R&D expenses.
Founded in 2020 by chief executive officer Jennifer Kyle, Condor Software is a San Diego, California technology company developing artificial intelligence-powered finance and accounting software tailored for the biopharmaceutical industry. The enterprise provides a cloud-based financial intelligence platform that automates clinical accruals, budget tracking, and scenario planning while consolidating operational and financial data for research and development expenses. By integrating with major clinical vendors and accounting systems, the platform utilizes proprietary ontologies to deliver audit-grade workflows for financial planning and accounting teams. The business operates on a software subscription model and has raised a total of $36 million in venture capital funding to scale its operations. This total includes a $24 million Series A financing round completed in March 2026, which was led by Insight Partners with additional backing from Felicis and 645 Ventures.
Condor Software, Inc. has raised $30.0M across 2 funding rounds.
Condor Software, Inc. has raised $30.0M in total across 2 funding rounds.
Condor Software, Inc. is a technology company that builds specialized finance and accounting software tailored for the biopharmaceutical industry, particularly focused on clinical trial financial management. Its flagship product, the Condor Cloud, automates clinical accruals, budget tracking, forecasting, and scenario planning, enabling finance, accounting, clinical operations, and FP&A teams to manage R&D finances with greater speed, accuracy, and control. The platform integrates seamlessly with major clinical and accounting systems, providing real-time financial insights that help biopharma companies optimize clinical portfolios and accelerate decision-making. Condor serves biotech and pharmaceutical companies, including publicly traded firms and Big 4 accounting firms, addressing the complex financial challenges in clinical research and development[1][2][3][4].
Founded in 2020 by Jennifer (Jen) Kyle, a CPA and financial consultant with deep experience in biopharma finance, Condor Software emerged from her firsthand observation of the inefficiencies and risks caused by manual spreadsheets, disconnected systems, and complex accrual processes in R&D financial management. Motivated by a personal connection to the impact of clinical trials and a desire to help bring life-saving treatments to patients faster, Kyle collaborated with industry leaders and Big 4 firms to design an enterprise-grade financial cloud solution purpose-built for biopharma. Early traction included adoption by leading biopharma companies and successful integration with clinical vendors, culminating in the launch of the Condor Cloud platform that revolutionizes clinical trial financial workflows[1][2].
Condor Software rides the growing trend of digital transformation in life sciences, particularly the urgent need for integrated, automated financial management in clinical R&D. With global biopharma R&D spending exceeding $300 billion annually, the timing is critical as companies seek to reduce costly inefficiencies and accelerate drug development timelines. Market forces such as increasing clinical trial complexity, regulatory demands, and the push for data-driven decision-making favor Condor’s cloud-based, AI-enhanced platform. By streamlining financial workflows and improving transparency, Condor influences the broader ecosystem by enabling biopharma companies to allocate resources more strategically and bring therapies to market faster[1][2][4].
Looking ahead, Condor Software is poised to expand its product suites and deepen its integration capabilities, further embedding itself as the financial backbone for biopharma R&D. Trends such as increased adoption of cloud computing, AI-driven analytics, and the growing importance of financial agility in clinical development will shape its evolution. As the company scales, its influence may extend beyond finance teams to broader clinical operations and strategic portfolio management, reinforcing its mission to accelerate life-saving treatments. Condor’s continued innovation and industry partnerships position it as a critical enabler in the future of biopharma financial intelligence[1][2][4].
Condor Software, Inc. has raised $30.0M in total across 2 funding rounds.
Condor Software, Inc.'s investors include Alex Leibowitz, 645 Ventures, Bramalea Partners, Felicis Ventures, Pamir Ventures, Prebys Ventures Fund, SNR, Accel, Blackbird Ventures Australia, Stewart Butterfield.
Condor Software, Inc. has raised $30.0M across 2 funding rounds. Most recently, it raised $24.0M Condor Software - Series A in March 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 18, 2026 | $24M Series A | Alex Leibowitz | 645 Ventures, Bramalea Partners, Felicis Ventures, Pamir Ventures, Prebys Ventures Fund, SNR | Announced |
| Feb 1, 2022 | $6M Seed | — | Accel, Blackbird Ventures Australia, Felicis Ventures, Stewart Butterfield | Announced |